Koh-i-noor Machinery a.s. acquires leading tooling and plastic injection molding supplier Ronas

Zurich, 6 January 2014

Press Release

As per 6 January 2014 Koh-i-noor Machinery a.s. acquired Ronas, a leading tooling and plastic injection molding supplier to the automotive industry in the Czech Republic. Ronas will be added to Koh-i-noor’s tooling platform Ponas. The acquisition will create one of the largest and advanced toolshop and plastic injection molding firms in the Czech Republic. For the owners of Ronas the transaction allows to terminate a long process to find a qualified new owner able to secure the future of the company.

Koh-i-noor holding a.s. is a EUR 120m revenue holding company which comprises of a select investment portfolio in four sectors: (1) machinery & engineering, (2) school and office supplies (3) healthcare and (4) energy. Ronas is Koh-i-noor’s fourth major add-on acquisition in the recent years. The transaction value was not revealed.

Ronas, privatized in 1992, has been a premium automotive supplier of plastic injection molded components with its own tooling shop located in the north-east of the Czech Republic, allowing high flexibility and an attractive price-to-value ratio for its customers. The company was privately owned by its founders and soon needed to find a qualified external successor for the company’s majority owner which allows him to retire.

Team members of Privilege Partners assisted Ronas’ owners to carefully invite and evaluate select qualified buyers as potential succession candidates, a process which took more than one year but lead to the desired outcome. “Koh-i-noor’s clear strategic vision, its impressive industry expertise combined with high integrity formed the basis of our choice” – said Mr. Libor Rak – the seller’s representative.

Privilege Partners is a premium independent advisory firm headquartered near Zurich/Switzerland which consists of a network of select investment and industry specialists in the areas of M&A, corporate finance and corporate development advisory.

For further information, please contact us.